Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EPAS1 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | MMS22L | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | SSPN | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | MTRF1 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | UBE2H | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | ITGA3 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | TMEM147 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | ERGIC3 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | EFEMP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |